• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与双螺旋丝相关的修饰tau蛋白的磷酸分析和去磷酸化

Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.

作者信息

Ksiezak-Reding H, Liu W K, Yen S H

机构信息

Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461.

出版信息

Brain Res. 1992 Dec 4;597(2):209-19. doi: 10.1016/0006-8993(92)91476-u.

DOI:10.1016/0006-8993(92)91476-u
PMID:1472994
Abstract

We performed phosphate analysis of tau proteins isolated from normal human brain, tau proteins associated with paired helical filaments (PHF-tau), and Alzheimer tau not associated with PHF. These tau fractions were of high purity. Normal and Alzheimer tau were purified by heat treatment, acid extraction and calmodulin-affinity chromatography with or without HPLC. Fractions containing primarily PHF-tau polypeptides of 60, 64 and 68 kDa and their degraded fragments were purified either on a sucrose density gradient as filaments (PHF) or by heat treatment and acid extraction as amorphous proteins (PHF-tau). PHF and PHF-tau were found to contain 6-8 mol phosphate/mol protein while normal and Alzheimer tau proteins contained 1.9 and 2.6 mol phosphate/mol protein, respectively. Upon 2-h incubation with alkaline phosphatase, PHF lost two of the phosphate groups without apparent changes in the stability and morphology of PHF. The released phosphate originated from the N-terminal half of PHF-tau as determined by immunoblotting with antibodies to epitopes blocked by phosphorylation. Tau-1 and E-2, and by a prominent shift in the electrophoretic mobility of some fragments of PHF-tau. The shift in mobility was not observed with the C-terminal fragments of 25-26 kDa, which retained the epitope to Tau 46. The results suggest that the phosphorylation sites not affected by phosphatase may be located in the 25-26 kDa C-terminal region of PHF-tau and may play a role in structural stability of PHF.

摘要

我们对从正常人脑中分离出的tau蛋白、与双螺旋丝相关的tau蛋白(PHF-tau)以及不与PHF相关的阿尔茨海默病tau蛋白进行了磷酸盐分析。这些tau蛋白组分具有高纯度。正常tau蛋白和阿尔茨海默病tau蛋白通过热处理、酸提取以及钙调蛋白亲和层析(有无高效液相色谱)进行纯化。主要含有60、64和68 kDa的PHF-tau多肽及其降解片段的组分,要么作为细丝在蔗糖密度梯度上纯化(PHF),要么通过热处理和酸提取作为无定形蛋白纯化(PHF-tau)。发现PHF和PHF-tau含有6 - 8摩尔磷酸盐/摩尔蛋白,而正常tau蛋白和阿尔茨海默病tau蛋白分别含有1.9和2.6摩尔磷酸盐/摩尔蛋白。与碱性磷酸酶孵育2小时后,PHF失去了两个磷酸基团,而PHF的稳定性和形态没有明显变化。通过用针对被磷酸化阻断的表位的抗体进行免疫印迹测定,释放的磷酸盐源自PHF-tau的N端一半。Tau-1和E-2,以及PHF-tau某些片段的电泳迁移率有显著变化。在25 - 26 kDa的C端片段中未观察到迁移率变化,这些片段保留了与Tau 46的表位。结果表明,不受磷酸酶影响的磷酸化位点可能位于PHF-tau的25 - 26 kDa C端区域,并且可能在PHF的结构稳定性中起作用。

相似文献

1
Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.与双螺旋丝相关的修饰tau蛋白的磷酸分析和去磷酸化
Brain Res. 1992 Dec 4;597(2):209-19. doi: 10.1016/0006-8993(92)91476-u.
2
The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments.胎儿tau蛋白的磷酸化程度与阿尔茨海默病配对螺旋丝中PHF-tau蛋白的磷酸化程度相当。
Brain Res. 1993 Nov 26;629(1):40-6. doi: 10.1016/0006-8993(93)90478-6.
3
Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.钙蛋白酶诱导的正常人tau蛋白以及与双螺旋丝相关的tau蛋白的蛋白水解作用。
Eur J Biochem. 1995 Oct 1;233(1):9-17. doi: 10.1111/j.1432-1033.1995.009_1.x.
4
Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205.成对螺旋丝的构象会阻止与胎儿tau蛋白共有的表位去磷酸化,但Ser199/202和Ser202/Thr205除外。
Brain Res. 2000 Feb 21;856(1-2):163-75. doi: 10.1016/s0006-8993(99)02391-4.
5
Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.阿尔茨海默病神经原纤维缠结中的tau蛋白。N端和C端区域与双螺旋丝及一个假定的异常磷酸化位点的位置存在差异关联。
Biochem J. 1991 Jan 1;273(Pt 1)(Pt 1):127-33. doi: 10.1042/bj2730127.
6
Detection of D-aspartate in tau proteins associated with Alzheimer paired helical filaments.在与阿尔茨海默病配对螺旋丝相关的tau蛋白中检测D-天冬氨酸。
Brain Res. 1995 Mar 27;675(1-2):183-9. doi: 10.1016/0006-8993(95)00061-t.
7
Identification of microtubule-associated protein tau isoforms in Alzheimer's paired helical filaments.阿尔茨海默病成对螺旋丝中微管相关蛋白tau异构体的鉴定
Brain Res Bull. 1997;43(5):501-8. doi: 10.1016/s0361-9230(97)80003-2.
8
Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.阿尔茨海默病配对螺旋丝。通过去磷酸化恢复生物活性。
FEBS Lett. 1994 Jul 25;349(1):104-8. doi: 10.1016/0014-5793(94)00650-4.
9
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.氢氟酸处理的tau蛋白聚集体(PHF)与正常tau蛋白具有相同的生化特性。
J Biol Chem. 1992 Jan 5;267(1):564-9.
10
Differential expression of exons 10 and 11 in normal tau and tau associated with paired helical filaments.外显子10和11在正常tau蛋白以及与成对螺旋丝相关的tau蛋白中的差异表达。
J Neurosci Res. 1995 Aug 1;41(5):583-93. doi: 10.1002/jnr.490410504.

引用本文的文献

1
Phosphorylation-Induced Self-Coacervation versus RNA-Assisted Complex Coacervation of Tau Proteins.磷酸化诱导的tau蛋白自凝聚与RNA辅助的复合凝聚
J Am Chem Soc. 2025 Mar 26;147(12):10172-10187. doi: 10.1021/jacs.4c14728. Epub 2025 Mar 12.
2
Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease.针对tau蛋白过度磷酸化诱导的聚集体的天然产物:阿尔茨海默病的潜在疗法。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400721. doi: 10.1002/ardp.202400721.
3
Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases.
以淀粉样蛋白为靶点用于神经退行性疾病的临床诊断。
Fundam Res. 2022 Nov 1;3(4):505-519. doi: 10.1016/j.fmre.2022.10.009. eCollection 2023 Jul.
4
Quantification of Methylation and Phosphorylation Stoichiometry.定量甲基化和磷酸化计量。
Methods Mol Biol. 2024;2754:221-235. doi: 10.1007/978-1-0716-3629-9_13.
5
Interaction of Tau with G-Protein-Coupled Purinergic P2Y12 Receptor by Molecular Docking and Molecular Dynamic Simulation.通过分子对接和分子动力学模拟研究 Tau 与 G 蛋白偶联嘌呤能 P2Y12 受体的相互作用。
Methods Mol Biol. 2024;2754:33-54. doi: 10.1007/978-1-0716-3629-9_2.
6
Tau oligomerization on microtubules in health and disease.健康与疾病状态下微管上的 Tau 蛋白寡聚化
Cytoskeleton (Hoboken). 2024 Jan;81(1):35-40. doi: 10.1002/cm.21785. Epub 2023 Sep 25.
7
DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers.DJ-1 分子伴侣活性通过与单体相互作用抑制 Tau 聚集倾向。
Biochemistry. 2023 Mar 7;62(5):976-988. doi: 10.1021/acs.biochem.2c00581. Epub 2023 Feb 22.
8
Alzheimer's disease: Pathophysiology and dental pulp stem cells therapeutic prospects.阿尔茨海默病:病理生理学与牙髓干细胞治疗前景
Front Cell Dev Biol. 2022 Sep 15;10:999024. doi: 10.3389/fcell.2022.999024. eCollection 2022.
9
The Impairment of Blood-Brain Barrier in Alzheimer's Disease: Challenges and Opportunities with Stem Cells.阿尔茨海默病中的血脑屏障损伤:干细胞面临的挑战与机遇。
Int J Mol Sci. 2022 Sep 4;23(17):10136. doi: 10.3390/ijms231710136.
10
Tau liquid-liquid phase separation: At the crossroads of tau physiology and tauopathy.tau 液液相分离:tau 生理学和 tau 病学的十字路口。
J Cell Physiol. 2024 Jun;239(6):e30853. doi: 10.1002/jcp.30853. Epub 2022 Aug 18.